Edition:
United States

Voyager Therapeutics Inc (VYGR.OQ)

VYGR.OQ on NASDAQ Stock Exchange Global Select Market

18.22USD
4:00pm EDT
Change (% chg)

$-1.68 (-8.44%)
Prev Close
$19.90
Open
$19.35
Day's High
$19.58
Day's Low
$18.11
Volume
221,691
Avg. Vol
175,261
52-wk High
$31.91
52-wk Low
$8.10

Select another date:

Thu, May 10 2018

BRIEF-Voyager Therapeutics Rpeorts Q1 GAAP Loss Per Share Of $0.63

* VOYAGER THERAPEUTICS ANNOUNCES FIRST QUARTER 2018 FINANCIAL RESULTS AND CORPORATE HIGHLIGHTS

BRIEF-Voyager Therapeutics Reports Q4 GAAP Loss Per Share $0.40

* VOYAGER THERAPEUTICS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS

BRIEF-Voyager Therapeutics Announces Longer-Term Data From Ongoing Phase 1B Trial Of VY-AADC For Advanced Parkinson’s Disease

* VOYAGER THERAPEUTICS ANNOUNCES LONGER-TERM DATA FROM ONGOING PHASE 1B TRIAL OF VY-AADC FOR ADVANCED PARKINSON’S DISEASE

BRIEF-Voyager Therapeutics And Abbvie Announce Global Strategic Collaboration

* VOYAGER THERAPEUTICS AND ABBVIE ANNOUNCE GLOBAL STRATEGIC COLLABORATION TO DEVELOP POTENTIAL NEW TREATMENTS FOR ALZHEIMER’S DISEASE AND OTHER TAU-RELATED NEURODEGENERATIVE DISEASES

BRIEF-Voyager Therapeutics Announces FDA Clearance Of Investigational NDA For VY-AADC

* VOYAGER THERAPEUTICS ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR VY-AADC FOR ADVANCED PARKINSON’S DISEASE

Select another date: